Boron is a trace mineral found in nuts, legumes, and leafy greens, and some preliminary research suggests it may influence testosterone levels. This has led to interest in whether boron supplements might help with erectile dysfunction (ED). However, there is currently no robust clinical evidence supporting boron as an effective treatment for ED. Men experiencing erectile difficulties should consult their GP for proper assessment and access to evidence-based treatments such as PDE5 inhibitors, which have proven efficacy. Understanding the current evidence on boron, alongside established ED management options, helps inform safe and effective decision-making.

What Is Boron and How Does It Work in the Body?

Boron is a trace mineral found naturally in various foods including nuts, legumes, dried fruits, and leafy green vegetables. It is not classified as an essential nutrient in the UK, and there are no established dietary reference values or recognised clinical deficiency syndrome in humans. The average European diet provides approximately 1–3 mg of boron daily, though intake varies considerably depending on dietary patterns.

Within the body, boron influences several metabolic pathways, though much of the evidence comes from preliminary research. Studies suggest it may contribute to bone health by affecting calcium, magnesium, and phosphorus metabolism. The mineral also appears to modulate hormone levels, particularly those involved in steroid hormone metabolism. Limited human studies have indicated that boron supplementation may influence testosterone and oestrogen levels, though the mechanisms remain incompletely understood. Some research suggests boron may have anti-inflammatory properties and affect vitamin D metabolism, though these effects require further investigation in humans.

Key physiological roles suggested by research include:

• Supporting bone mineralisation and skeletal health

• Modulating steroid hormone metabolism

• Potentially influencing inflammatory pathways

• Affecting cell membrane function

Boron is absorbed efficiently in the small intestine and excreted primarily through urine. The body does not store large quantities, making regular dietary intake important for maintaining adequate levels. Understanding boron's biological functions provides context for examining its potential effects on sexual health and erectile function.

Does Boron Help with Erectile Dysfunction?

The relationship between boron supplementation and erectile dysfunction (ED) remains poorly established, with no high-quality clinical evidence to support its use as a treatment. No boron-containing medicine has a UK marketing authorisation for the treatment of erectile dysfunction, and there are no randomised controlled trials demonstrating benefit for this condition.

A small human study published in 2011 (Naghii et al.) found that 10 mg of boron daily for one week increased free testosterone levels in healthy male volunteers. Theoretically, higher testosterone might benefit libido and sexual function in men with confirmed hypogonadism. However, this research involved a very small sample size, short duration, and did not examine erectile function as an outcome. Importantly, most men with ED do not have clinically low testosterone, and the condition typically results from vascular, neurological, or psychological factors rather than hormonal deficiency alone. When hypogonadism is suspected, testosterone testing should be performed on a morning blood sample and interpreted in clinical context.

Current evidence limitations:

• No randomised controlled trials specifically examining boron for ED

• Unclear whether testosterone changes translate to functional improvements in erectile function

• Uncertain optimal dosing or treatment duration

• No comparison with established ED treatments

Men experiencing ED should consult their GP for proper assessment rather than self-treating with supplements. Effective, evidence-based treatments are available through the NHS, and underlying health conditions contributing to ED require appropriate medical evaluation and management. Further information is available through NICE Clinical Knowledge Summaries (Erection problems) and NHS online resources.

Evidence-Based Treatments for Erectile Dysfunction

Erectile dysfunction affects a significant proportion of men, particularly those over 40 years of age. The National Institute for Health and Care Excellence (NICE) provides clear guidance on the assessment and management of this condition, emphasising the importance of addressing underlying causes and offering treatments with proven efficacy.

First-line pharmacological treatments recommended by NICE include phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil and tadalafil, which are commonly available on NHS prescription. Vardenafil and avanafil may also be prescribed, though availability varies by local formulary. These medications work by enhancing the effects of nitric oxide, a natural chemical that relaxes muscles in the penis and increases blood flow during sexual stimulation. PDE5 inhibitors have robust evidence supporting their effectiveness, with success rates typically ranging from 60–80% depending on the underlying cause of ED.

Important contraindications and cautions apply to PDE5 inhibitors. They must not be used with nitrates (e.g., glyceryl trinitrate) or riociguat due to the risk of severe hypotension. Caution is required in men taking alpha-blockers, and treatment should be avoided in those with unstable cardiovascular disease. Men should be assessed for cardiovascular stability before initiating treatment. Detailed prescribing information is available in the British National Formulary (BNF) and individual Summary of Product Characteristics (SmPC) documents via the electronic Medicines Compendium (eMC).

Before initiating treatment, comprehensive assessment is essential. GPs should evaluate cardiovascular risk factors, as ED is often an early marker of cardiovascular disease and shares common risk factors including hypertension, diabetes, hyperlipidaemia, and smoking. Cardiovascular risk stratification (e.g., using QRISK) is recommended. Blood tests may include HbA1c or fasting glucose, fasting lipid profile, and morning testosterone levels if hypogonadism is suspected clinically. Blood pressure and body mass index (BMI) should be recorded, and a medication review conducted to identify drugs that may contribute to ED. Addressing modifiable risk factors forms an important part of management.

Additional evidence-based approaches include:

• Lifestyle modifications: Weight loss, increased physical activity, smoking cessation, and reducing alcohol intake

• Psychological interventions: Cognitive behavioural therapy or psychosexual counselling, particularly when psychological factors contribute

• Vacuum erection devices: Mechanical aids that draw blood into the penis

• Intracavernosal injections: Alprostadil injections for men who cannot use or do not respond to oral medications

• Penile prosthesis surgery: Reserved for refractory cases

Referral and red-flag guidance: Men with Peyronie's disease (penile curvature or pain), complex endocrine abnormalities, or suspected neurological causes should be referred to specialist services. Priapism (erection lasting more than 4 hours) is a medical emergency requiring urgent assessment and treatment.

Men should be encouraged to discuss ED openly with healthcare professionals, as effective treatments are available and the condition may indicate underlying health issues requiring attention. Further guidance is available through NICE Clinical Knowledge Summaries and NHS online resources.

Safety Considerations When Taking Boron Supplements

Whilst boron is generally considered safe at dietary intake levels, supplementation requires careful consideration. The European Food Safety Authority (EFSA) Scientific Committee on Food has established a tolerable upper intake level (UL) of 10 mg per day for adults. Exceeding this amount may increase the risk of adverse effects, though toxicity from boron is relatively uncommon at moderate supplementation levels.

Potential adverse effects associated with excessive boron intake include gastrointestinal disturbances such as nausea, vomiting, and diarrhoea. Toxicity has been reported at very high exposures (typically gram-level doses), with effects including dermatitis, alopecia, and central nervous system disturbances. However, such extreme intakes are unlikely with standard supplementation.

Boron may interact with certain medications and health conditions, though clinically significant interactions are not well established. Men taking hormone therapies should exercise particular caution, as boron appears to influence steroid hormone metabolism. Those with kidney disease require medical supervision, as impaired renal function affects boron excretion and may lead to accumulation. If you are taking any prescribed medicines or have existing health conditions, seek clinical advice before starting boron supplements.

Important safety advice:

• Consult your GP before starting boron supplements, particularly if you have existing health conditions or take prescribed medicines

• Inform healthcare professionals about all supplements you take

• Do not exceed the EFSA tolerable upper intake level (10 mg/day) without medical supervision

• Purchase supplements from reputable sources to ensure quality and accurate labelling

• Be aware that food supplements are not subject to the same rigorous testing as licensed medicines

• Report any suspected side effects from medicines or herbal remedies via the MHRA Yellow Card Scheme

Men considering boron supplementation for erectile dysfunction should discuss this with their GP. Self-treatment may delay proper diagnosis of underlying conditions and access to effective, evidence-based therapies. The UK Food Standards Agency advises consumers to be cautious about health claims made for supplements, particularly those suggesting treatment of medical conditions without supporting clinical evidence. Further information on supplement safety and regulation is available through the MHRA and FSA.

Frequently Asked Questions